Egészségügy 24 február 2026

UnitedHealth stock extends slide after bell as Medicare Advantage deadline nears

Az UnitedHealth részvényei tovább esnek a zárás után, ahogy közeleg a Medicare Advantage határideje

UnitedHealth Group shares fell 2.6% to $273.95 in after-hours trading Tuesday, deepening a two-day drop of about 5.5%. The decline comes as investors await the final 2027 Medicare Advantage reimbursement rates, with the public comment period closing February 25. Other managed care stocks, including Humana and Elevance, also slipped despite gains in the broader market.
február 25, 2026
Why SLS stock is jumping premarket: SELLAS Life Sciences puts REGAL Phase 3 countdown back in play

Miért ugrik az SLS részvény az előpiacon: a SELLAS Life Sciences újraindítja a REGAL 3. fázisú visszaszámlálást

SELLAS Life Sciences rose 3.4% to $4.29 in premarket trading Monday after closing at $4.15 Friday on heavy volume. Traders are watching for results from its phase 3 AML trial, with final survival data expected by mid-March. Short interest stands at 41.3 million shares, about 24% of float. SELLAS reported $71.8 million in cash at year-end.
február 24, 2026